(Q34731509)

4 August 2017

1 reference

title

Malignant mixed mesodermal tumours: biology and clinical aspects (English)

1 reference

4 August 2017

Gourley C

1

1 reference

4 August 2017

Al-Nafussi A

2

1 reference

4 August 2017

Abdulkader M

3

1 reference

4 August 2017

Smyth JF

4

1 reference

4 August 2017

Gabra H

5

1 reference

4 August 2017

publication date

1 July 2002

1 reference

European Journal of Cancer

4 August 2017

published in

1 reference

4 August 2017

volume

38

1 reference

4 August 2017

issue

11

1 reference

4 August 2017

page(s)

1437-1446

1 reference

Malignant mixed mullerian tumours of gynaecological origin: chemosensitive but aggressive tumours

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed Müllerian tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed müllerian tumors of the ovary: experience with surgical cytoreduction and combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed müllerian tumor of the fallopian tube

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed Müllerian tumor of the fallopian tube: report of two cases and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Primary malignant mixed Müllerian tumor of the vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Primary malignant mixed Müllerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Carcinosarcoma of the spleen. An extragenital malignant mixed müllerian tumor?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Patterns of recurrence in malignant mixed müllerian tumor of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mullerian mixed tumors of the uterus a study of 21 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Postirradiation mixed müllerian tumors of the uterus. A comparative clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

The endometrium in breast cancer patients on tamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Endometrial mesodermal mixed tumor occurring after tamoxifen treatment: report on a new case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Clinicopathologic analysis of uterine malignant mixed müllerian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Management of malignant, mixed mesodermal tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed müllerian tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Extrauterine pelvic malignant mixed mesodermal tumors. A study of 10 cases with immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: report of eight cases and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Histogenesis of ovarian malignant mixed mesodermal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed müllerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

p53 immunostaining suggests that uterine carcinosarcomas are monoclonal

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Characteristics of rhabdomyosarcoma cell lines derived from uterine carcinosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Loss of H19 imprinting and up-regulation of H19 and SNRPN in a case with malignant mixed Müllerian tumor of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed müllerian tumors of the ovary: histopathologic and clinical review of 36 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Homologous mixed müllerian tumors (carcinosarcoma) confined to endometrial polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Mesenchymal tumors of the uterus. 3. A clinical and pathologic study of 31 carcinosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Solid teratomas and mixed müllerian tumors of the ovary: a clinical, histological, and immunocytochemical comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

1 reference

7 January 2021

Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Uterine sarcoma: steroid receptors and response to hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Progesterone receptor levels independently predict survival in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Mixed Mullerian tumors of the uterine corpus: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Effects of irradiation on mixed müllerian tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Mixed müllerian tumours of the uterus--prognostic factors: a clinical and histopathologic study of 147 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Uterine sarcomas: analysis of failures with special emphasis on the use of adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Results of primary and adjuvant radiotherapy in the treatment of mixed Müllerian tumors of the corpus uteri

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Carcinosarcoma of the ovary treated over a 10-year period at the Christie Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Chemotherapy for malignant mixed Müllerian tumors of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

Malignant mixed mullerian tumors of the ovary. An analysis of two long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900114-4

7 January 2021

10.1016/S0959-8049(02)00114-4

Identifiers

DOI

1 reference

4 August 2017

1 reference